Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad s Q1 Revenues Rise, Income Drops

NEW YORK, May 7 (GenomeWeb News) - Bio-Rad yesterday reported increased revenues but a drop in income for the first quarter of 2004.

 

Bio-Rad's revenues increased 8.4 percent year-over-year to $266.6 million in the quarter, from $246 million in the comparable quarter of 2003.

 

Net income for the quarter decreased to $22 million, or $.86 per share, from $26.4 million, or $1.04 per share in the year-ago period.

 

R&D expenses rose to $25.2 million, from $21.4 million a year ago.

 

As of March 31, 2004, Bio-Rad had $141.5 million in cash and cash equivalents.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.